FDA Clearance Tracker · K200206
AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter
Last checked: Nov 19, 2026Latest source record: Feb 27, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Feb 27, 2020
Substantially Equivalent
Time to decision
30 days
Received Jan 28, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K200206
- Device name
- AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter
- Applicant
- Stryker Neurovascular
- Applicant location
- Fremont, CA
- Received
- Jan 28, 2020
- Decided
- Feb 27, 2020
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QJP (Catheter, Percutaneous, Neurovasculature).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K200206
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Stryker Neurovascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261649 · Decided Oct 9, 2026 · 143 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K261889 · Decided Jul 1, 2026 · 26 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K253032 · Decided Feb 11, 2026 · 142 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.